Sight Sciences, Inc. (SGHT)
Data as of , from SEC Form 4 filings.
See up to 3 months of SGHT. The 7-day demo opens the 1M and 3M ranges and puts SGHT on your watchlist.
Start 7-day demoLatest SGHT insider trades
- Brenton Taylor - OfficerOpen-market sale$26K
Alison Bauerlein - Officer
About Sight Sciences, Inc. (SGHT)
Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. The company operates through two segments: Interventional Glaucoma, which generates the majority of revenue and includes the OMNI Surgical System family of products and the SION Surgical Instrument used in minimally invasive glaucoma surgery to reduce intraocular pressure in adult patients with open-angle glaucoma; and Interventional Dry Eye, which includes the TearCare System, an interventional device designed to melt and facilitate the removal of meibomian gland obstructions and restore gland functionality in adult patients with evaporative dry eye disease.
- MENLO PARK, CA
- 186
- 2021
- XNAS
SGHT Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 5 | 72,906 | $653K |
| Grant or award | 1 | 181,818 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
SGHT insider transactions (Form 4)
2380 Form 4 filings on record, the earliest from Oct 3, 2024, newest first. Filing history page 3 of 3.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jeremy B. Hayden - Officer | Open-market sale | Common Stock | 9,160 | $4.17 | $38K | |
| David Badawi - Officer | Open-market sale | Common Stock | 5,679 | $4.17 | $24K | |
| Alison Bauerlein - Officer | Open-market sale | Common Stock | 19,260 | $4.10 | $79K | |
| Matthew Link - Officer | Open-market sale | Common Stock | 4,889 | $4.10 | $20K | |
| Paul Badawi - Officer | Open-market sale | Common Stock | 23,637 | $4.15 | $98K | |
 Gerhard F. Burbach | Grant or award | Common Stock | 74,766 | $0.00 | - | |
| Manohar K. Raheja - Officer | Open-market purchase | Common Stock | 5,000 | $3.85 | $19K | |
| Manohar K. Raheja - Officer | Open-market purchase | Common Stock | 3,376 | $3.89 | $13K | |
| Manohar K. Raheja - Officer | Open-market purchase | Common Stock | 4,624 | $3.99 | $18K | |
| Staffan Encrantz | Open-market sale | Common Stock | 551,802 | $3.73 | $2.06M | |
| Staffan Encrantz | Open-market purchase | Common Stock | 551,802 | $3.73 | $2.06M | |
| Manohar K. Raheja - Officer | Open-market purchase | Common Stock | 2,000 | $3.70 | $7K | |
| Brenton Taylor - Officer | Grant or award | Common Stock | 160,000 | $4.59 | $734K | |
| Manohar K. Raheja - Officer | Grant or award | Common Stock | 96,000 | $4.59 | $441K | |
| Matthew Link - Officer | Open-market sale | Common Stock | 20,487 | $5.98 | $122K | |
| Matthew Link - Officer | Open-market sale | Common Stock | 21,831 | $5.61 | $122K | |
| Matthew Link - Officer | Open-market sale | Common Stock | 20,734 | $5.91 | $122K | |
| Matthew Link - Officer | Open-market sale | Common Stock | 20,970 | $5.84 | $122K | |
| Paul Badawi - Officer | Open-market sale | Common Stock | 12,727 | $5.99 | $76K | |
| Jeremy B. Hayden - Officer | Open-market sale | Common Stock | 4,878 | $6.08 | $30K | |
| David Badawi - Officer | Open-market sale | Common Stock | 3,167 | $5.99 | $19K | |
| Alison Bauerlein - Officer | Open-market sale | Common Stock | 10,130 | $6.08 | $62K | |
| Sam Boong Park - Officer | Open-market sale | Common Stock | 3,403 | $6.08 | $21K |
Recent SGHT Form 144 notices of proposed sale
3An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| Bauerlein Alison | Officer | 25,260 | $224K | View on EDGAR | |
| Taylor Brenton | Officer | 2,988 |
SGHT insider trading FAQ
What is the latest insider trade for SGHT?
Sight Sciences, Inc. (SGHT) had 6 insider filings in the last 90 days, with the most recent on 2026-10-05. The full record for SGHT runs to 80 Form 4 filings, the earliest from 2024-10-03. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying SGHT stock?
No insider purchases of SGHT were filed in the last 90 days. 7 purchases are on record for this company.
How many insiders are selling SGHT stock?
5 insider sales of SGHT were filed in the last 90 days, totaling $653K.
Where can I see SGHT SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects SGHT Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Brenton Taylor view on EDGAR
- - Alison Bauerlein view on EDGAR
- - James Rodberg view on EDGAR
- - David Badawi view on EDGAR
- - Paul Badawi view on EDGAR
- - Kashif Rashid view on EDGAR
- - Jeremy B. Hayden view on EDGAR
- - James Rodberg view on EDGAR
- - David Badawi view on EDGAR
Related companies with recent insider activity
Learn more
- Insider selling: signal or noise?
- Why most insider sales are routine, and the few patterns worth a second look.
- Form 144 vs Form 4
- A Form 144 announces a planned sale; the Form 4 reports it after it happens.
- Insider activity in Health Care
- Where SGHT's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow SGHT with a 7-day demo
- SGHT on your watchlist
- Every SGHT Form 4 filing on record
- Up to 3 months of SGHT price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
